SCHEMBL26679905

SCHEMBL26679905

O=c1ccc2c(-c3cccc(CN[SH](=O)=O)c3)ccnc2[nH]1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ NUDT1 P36639 9/20 0.40
▸ CHUK O15111 3/20 0.38
▸ MAPK8 P45983 2/20 0.38
▸ INSR P06213 1/20 0.38
▸ CAMKK2 Q96RR4 1/20 0.38
▸ PRKCI P41743 1/20 0.38
▸ IKBKB O14920 2/20 0.37
▸ AURKB Q96GD4 2/20 0.37
▸ AURKA O14965 1/20 0.37
▸ INCENP Q9NQS7 1/20 0.37
▸ TPX2 Q9ULW0 1/20 0.37
▸ PIK3C3 Q8NEB9 1/20 0.36
▸ ENPP1 P22413 1/20 0.36
▸ PDE3B Q13370 1/20 0.35
▸ PDE3A Q14432 1/20 0.35
▸ CCNK O75909 1/20 0.35
▸ CDK12 Q9NYV4 1/20 0.35
▸ LRRK2 Q5S007 2/20 0.35
▸ TNIK Q9UKE5 1/20 0.35
▸ DAPK3 O43293 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26679987 0.85 ENPP1 (0.38) CHUKMAPK8INSRCAMKK2IKBKB
SCHEMBL24600967 0.83 PRKCI (0.47) NUDT1CHUKMAPK8INSRCAMKK2
SCHEMBL24600623 0.83 NUDT1 (0.40) NUDT1CHUKMAPK8INSRCAMKK2
Hydrochloric Acid SCHEMBL29691611 0.82 PRKCI (0.47) NUDT1CHUKMAPK8INSRCAMKK2
Hydrochloric Acid SCHEMBL26679985 0.82 PRKCI (0.47) NUDT1CHUKMAPK8INSRCAMKK2
SCHEMBL29691600 0.82 ENPP1 (0.54) NUDT1CHUKMAPK8INSRCAMKK2
SCHEMBL24600622 0.82 ENPP1 (0.54) NUDT1CHUKMAPK8INSRCAMKK2
SCHEMBL26679983 0.80 NUDT1 (0.43) NUDT1CHUKMAPK8INSRCAMKK2
SCHEMBL26679912 0.80 BTK (0.39) CHUKPRKCIIKBKBENPP1PDE3B
Hydrochloric Acid SCHEMBL26679859 0.80 CDK9 (0.36) NUDT1ENPP1CDK9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240140944-A1 NOVEL NAPHTHYRIDINONE DERIVATIVE HAVING INHIBITORY ACTIVITY AGAINST ECTONUCLEOTIDE PYROPHOSPHATASE-PHOSPHODIESTERASE AND USE THEREOF TXINNO BIOSCIENCE INC. (KR) 2024-05-02 — — US claimed
EP-4276100-A1 NOVEL NAPHTHYRIDINONE DERIVATIVE HAVING INHIBITORY ACTIVITY AGAINST ECTONUCLEOTIDE PYROPHOSPHATASE-PHOSPHODIESTERASE AND USE THEREOF Txinno Bioscience Inc. (KR) 2023-11-15 — — EP claimed
CN-116669726-A Novel naphthyridinone derivatives having inhibitory activity against exonuclease-phosphodiesterase and use thereof 谛希诺生物科技有限公司 2023-08-29 — — CN claimed
US-20240140944-A1 NOVEL NAPHTHYRIDINONE DERIVATIVE HAVING INHIBITORY ACTIVITY AGAINST ECTONUCLEOTIDE PYROPHOSPHATASE-PHOSPHODIESTERASE AND USE THEREOF TXINNO BIOSCIENCE INC. (KR) 2024-05-02 — — US disclosed
EP-4276100-A1 NOVEL NAPHTHYRIDINONE DERIVATIVE HAVING INHIBITORY ACTIVITY AGAINST ECTONUCLEOTIDE PYROPHOSPHATASE-PHOSPHODIESTERASE AND USE THEREOF Txinno Bioscience Inc. (KR) 2023-11-15 — — EP disclosed
CN-116669726-A Novel naphthyridinone derivatives having inhibitory activity against exonuclease-phosphodiesterase and use thereof 谛希诺生物科技有限公司 2023-08-29 — — CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240140944-A1 NOVEL NAPHTHYRIDINONE DERIVATIVE HAVING INHIBITORY ACTIVITY AGAINST ECTONUCLEOTIDE PYROPHOSPHATASE-PHOSPHODIESTERASE AND USE THEREOF ENPP1, ENPP3, ENTPD5 NUDT1 53/4885CHUK 747/4885MAPK8 1209/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback